Holdings of MUTUAFONDO SALUD, FI
MUTUACTIVOS, S.A., S.G.I.I.C. ·40 declared positions · as of Dec 31, 2025
Original filing · Net assets 17.8M € · Ten largest lines: 37.9 % of the equity sleeve
Sector breakdown
- Health care 47.9 %
- Materials 2.2 %
- Unattributed 49.9 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- EUR 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 71.6 %
- JP 7.1 %
- BE 4.9 %
- CH 4.9 %
- FR 4.1 %
- DK 3.4 %
- FI 2.1 %
- SE 1.8 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 25 | 12.5M € | 71.64 % |
| 2 | JP | 4 | 1.2M € | 7.13 % |
| 3 | BE | 2 | 863.5K € | 4.93 % |
| 4 | CH | 3 | 863.2K € | 4.93 % |
| 5 | FR | 2 | 714.9K € | 4.08 % |
| 6 | DK | 2 | 589.4K € | 3.36 % |
| 7 | FI | 1 | 365.7K € | 2.09 % |
| 8 | SE | 1 | 322K € | 1.84 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 1M € | 5.84 % | |
| 2 | Boston Scientific Corp | 835.7K € | 4.69 % | |
| 3 | Gilead Sciences Inc | 751.1K € | 4.21 % | |
| 4 | Intuitive Surgical Inc | 682.8K € | 3.83 % | |
| 5 | Amgen Inc | 677.7K € | 3.80 % | |
| 6 | BioMarin Pharmaceutical Inc | 571.5K € | 3.20 % | |
| 7 | Halozyme Therapeutics Inc | 560.4K € | 3.14 % | |
| 8 | UCB SA | 550.2K € | 3.08 % | |
| 9 | Penumbra Inc | 492.6K € | 2.76 % | |
| 10 | Bristol-Myers Squibb Co | 483.2K € | 2.71 % | |
| 11 | IDEXX Laboratories Inc | 471.1K € | 2.64 % | |
| 12 | Neurocrine Biosciences Inc | 461.6K € | 2.59 % | |
| 13 | Solventum Corp | 444.2K € | 2.49 % | |
| 14 | Cigna Group/The | 436.5K € | 2.45 % | |
| 15 | Stryker Corp | 435.4K € | 2.44 % | |
| 16 | Masimo Corp | 423.5K € | 2.37 % | |
| 17 | ResMed Inc | 403.4K € | 2.26 % | |
| 18 | STERIS PLC | 401.5K € | 2.25 % | |
| 19 | Insulet Corp | 396.9K € | 2.22 % | |
| 20 | Quest Diagnostics Inc | 393.4K € | 2.21 % | |
| 21 | Bio-Rad Laboratories Inc | 391.6K € | 2.20 % | |
| 22 | Incyte Corp | 389.9K € | 2.19 % | |
| 23 | Otsuka Holdings Co Ltd | 386K € | 2.16 % | |
| 24 | Ipsen SA | 381.3K € | 2.14 % | |
| 25 | Edwards Lifesciences Corp | 379.3K € | 2.13 % | |
| 26 | Orion Oyj | 365.7K € | 2.05 % | |
| 27 | Universal Health Services Inc | 361.2K € | 2.02 % | |
| 28 | Shionogi & Co Ltd | 353.8K € | 1.98 % | |
| 29 | DaVita Inc | 347.5K € | 1.95 % | |
| 30 | EssilorLuxottica SA | 333.6K € | 1.87 % | |
| 31 | Galderma Group AG | 330.7K € | 1.85 % | |
| 32 | Swedish Orphan Biovitrum AB | 322K € | 1.81 % | |
| 33 | Encompass Health Corp | 316.9K € | 1.78 % | |
| 34 | Argenx SE | 313.2K € | 1.76 % | |
| 35 | Kyowa Kirin Co Ltd | 303.7K € | 1.70 % | |
| 36 | Coloplast A/S | 299.9K € | 1.68 % | |
| 37 | Demant A/S | 289.4K € | 1.62 % | |
| 38 | Straumann Holding AG | 289.2K € | 1.62 % | |
| 39 | Sonova Holding AG | 243.3K € | 1.36 % | |
| 40 | Hoya Corp | 206.1K € | 1.16 % |